Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976201756> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W1976201756 endingPage "317" @default.
- W1976201756 startingPage "315" @default.
- W1976201756 abstract "In recent years, we have seen tremendous progress in our ability to achieve durable responses in patients with multiple myeloma. At the center of this progress, we have the development of 2 unrelated classes of drugs: proteasome inhibitors such as bortezomib and immunomodulatory drugs such as thalidomide and lenalidomide. The depth and durability of responses attained with these agents in the first-line setting has raised the possibility that they may be considered primary therapy. The Eastern Cooperative Oncology Group E1A05 clinical trial addresses the potential role of bortezomib and dexamethasone (VD) or VD plus lenalidomide (VRD) as primary first-line therapy. This clinical trial enrolls patients who have completed a dexamethasone-based induction (excluding patients using bortezomib). Assuming that most patients entering this clinical trial have been previously treated with thalidomide or lenalidomide, the trial will test whether switching to a proteasome inhibitor (VD arm) versus adding a proteasome inhibitor (VRD) results in superior longterm disease control. Patients entering this clinical trial will have deferred stem cell transplantation until the time of relapse. The primary endpoint of the trial is progression-free survival. By using an alkylator-free consolidation and reserving stem cell transplantation until the time of relapse, we hope that these treatment strategies will further prolong the survival of patients with myeloma." @default.
- W1976201756 created "2016-06-24" @default.
- W1976201756 creator A5003015868 @default.
- W1976201756 creator A5066940168 @default.
- W1976201756 date "2008-10-01" @default.
- W1976201756 modified "2023-10-16" @default.
- W1976201756 title "Consolidation Therapy with Bortezomib/Lenalidomide/Dexamethasone Versus Bortezomib/Dexamethasone After a Dexamethasone-Based Induction Regimen in Patients with Multiple Myeloma: A Randomized Phase III Trial" @default.
- W1976201756 cites W182568540 @default.
- W1976201756 cites W1992538067 @default.
- W1976201756 cites W2017303578 @default.
- W1976201756 cites W2020778579 @default.
- W1976201756 cites W2021954218 @default.
- W1976201756 cites W2032262113 @default.
- W1976201756 cites W2044436186 @default.
- W1976201756 cites W2059733579 @default.
- W1976201756 cites W2083107653 @default.
- W1976201756 cites W2102591890 @default.
- W1976201756 cites W2107057207 @default.
- W1976201756 cites W2110385671 @default.
- W1976201756 cites W2111650326 @default.
- W1976201756 cites W2124560610 @default.
- W1976201756 cites W2148672632 @default.
- W1976201756 cites W2168929741 @default.
- W1976201756 cites W2553602297 @default.
- W1976201756 cites W2580586341 @default.
- W1976201756 cites W2594644475 @default.
- W1976201756 cites W2979474503 @default.
- W1976201756 cites W3145716452 @default.
- W1976201756 cites W4232496617 @default.
- W1976201756 doi "https://doi.org/10.3816/clm.2008.n.046" @default.
- W1976201756 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18854289" @default.
- W1976201756 hasPublicationYear "2008" @default.
- W1976201756 type Work @default.
- W1976201756 sameAs 1976201756 @default.
- W1976201756 citedByCount "12" @default.
- W1976201756 countsByYear W19762017562012 @default.
- W1976201756 countsByYear W19762017562014 @default.
- W1976201756 countsByYear W19762017562016 @default.
- W1976201756 countsByYear W19762017562019 @default.
- W1976201756 countsByYear W19762017562023 @default.
- W1976201756 crossrefType "journal-article" @default.
- W1976201756 hasAuthorship W1976201756A5003015868 @default.
- W1976201756 hasAuthorship W1976201756A5066940168 @default.
- W1976201756 hasConcept C126322002 @default.
- W1976201756 hasConcept C143998085 @default.
- W1976201756 hasConcept C203092338 @default.
- W1976201756 hasConcept C2776063141 @default.
- W1976201756 hasConcept C2776364478 @default.
- W1976201756 hasConcept C2777478702 @default.
- W1976201756 hasConcept C2778367456 @default.
- W1976201756 hasConcept C2779050716 @default.
- W1976201756 hasConcept C2779609412 @default.
- W1976201756 hasConcept C2780401358 @default.
- W1976201756 hasConcept C2781413609 @default.
- W1976201756 hasConcept C2911091166 @default.
- W1976201756 hasConcept C535046627 @default.
- W1976201756 hasConcept C71924100 @default.
- W1976201756 hasConceptScore W1976201756C126322002 @default.
- W1976201756 hasConceptScore W1976201756C143998085 @default.
- W1976201756 hasConceptScore W1976201756C203092338 @default.
- W1976201756 hasConceptScore W1976201756C2776063141 @default.
- W1976201756 hasConceptScore W1976201756C2776364478 @default.
- W1976201756 hasConceptScore W1976201756C2777478702 @default.
- W1976201756 hasConceptScore W1976201756C2778367456 @default.
- W1976201756 hasConceptScore W1976201756C2779050716 @default.
- W1976201756 hasConceptScore W1976201756C2779609412 @default.
- W1976201756 hasConceptScore W1976201756C2780401358 @default.
- W1976201756 hasConceptScore W1976201756C2781413609 @default.
- W1976201756 hasConceptScore W1976201756C2911091166 @default.
- W1976201756 hasConceptScore W1976201756C535046627 @default.
- W1976201756 hasConceptScore W1976201756C71924100 @default.
- W1976201756 hasIssue "5" @default.
- W1976201756 hasLocation W19762017561 @default.
- W1976201756 hasLocation W19762017562 @default.
- W1976201756 hasOpenAccess W1976201756 @default.
- W1976201756 hasPrimaryLocation W19762017561 @default.
- W1976201756 hasRelatedWork W1966357810 @default.
- W1976201756 hasRelatedWork W1974135782 @default.
- W1976201756 hasRelatedWork W1980068016 @default.
- W1976201756 hasRelatedWork W2022036807 @default.
- W1976201756 hasRelatedWork W2030475312 @default.
- W1976201756 hasRelatedWork W2041042375 @default.
- W1976201756 hasRelatedWork W2058009067 @default.
- W1976201756 hasRelatedWork W2462844398 @default.
- W1976201756 hasRelatedWork W2979889274 @default.
- W1976201756 hasRelatedWork W3042537788 @default.
- W1976201756 hasVolume "8" @default.
- W1976201756 isParatext "false" @default.
- W1976201756 isRetracted "false" @default.
- W1976201756 magId "1976201756" @default.
- W1976201756 workType "article" @default.